480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) (480S)
This study has been completed.
Sponsor:
Biolex Therapeutics, Inc.
Information provided by (Responsible Party):
Biolex Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00953589
First received: August 5, 2009
Last updated: February 1, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2011 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |